Company intelligence / Profile preview

BioArray Solutions

Warren, New Jersey, United Statesimmdocs.immucor.com ↗

Ownership: Private
Development stage: Commercial

Overview

BioArray Solutions developed proprietary microarray-based diagnostic platforms—most notably the BeadChip™ system—for high-throughput genotyping and multiplexed molecular diagnostics. Their technologies were adopted by leading institutions in transfusion and transplantation medicine, with FDA clearance obtained for certain assays. The company was acquired by Immucor in a $117 million cash deal in June/July of 2008.

Therapeutic areas: ImmunologyInfectious DiseasesRare DiseasesHematology
Modalities: Device (diagnostic platform)Microarray-based diagnosticsNucleic acid analysis technologyProtein analysis technology
Industry: Molecular Diagnostics

Partnerships

Not specified; products adopted by leading institutions in the field

Beyond the preview

Go deeper on BioArray Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioArray Solutions.

Explore the full profile